Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. 1998

A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
Medizinische Universitätsklinik, Institut für Klinische Biochemie und Pathobiochemie, Josef-Schneider Strasse 2, 97080 Würzburg, Germany.

The development and functional analysis of a monoclonal antibody (16C2) are reported; the antibody recognizes vasodilator-stimulated phosphoprotein (VASP; an established substrate of both cAMP- and cGMP-dependent protein kinase) only when serine 239 is phosphorylated. VASP serine 239 represents one of the best characterized cGMP-dependent protein kinase phosphorylation sites in vitro and in intact cells. Experiments with purified, recombinant human VASP and various VASP constructs with mutated phosphorylation sites (S157A, S239A, T278A) and experiments with intact cells (human/rat platelets and other cells) treated with cyclic nucleotide-elevating agents demonstrated the specificity of the monoclonal antibody 16C2. Quantitative analysis of the VASP shift from 46 to 50 kDa (indicating VASP serine 157 phosphorylation) and the appearance of VASP detected by the 16C2 monoclonal antibody (VASP serine 239 phosphorylation) in human platelets stimulated by selective protein kinase activators confirmed that serine 239 is the VASP phosphorylation site preferred by cGMP-dependent protein kinase in intact cells. Immunofluorescence experiments with human platelets treated with cGMP analogs showed that the 16C2 monoclonal antibody also detects VASP serine 239 phosphorylation in situ at established intracellular localization sites. Analysis of VASP serine 239 phosphorylation by the 16C2 antibody appears to be the best method presently available to measure cGMP-dependent protein kinase activation in intact cells. Also, the 16C2 antibody promises to be an excellent tool for the evaluation of VASP function in intact cells.

UI MeSH Term Description Entries
D008840 Microfilament Proteins Monomeric subunits of primarily globular ACTIN and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell. Actin Binding Protein,Actin-Binding Protein,Actin-Binding Proteins,Microfilament Protein,Actin Binding Proteins,Binding Protein, Actin,Protein, Actin Binding,Protein, Actin-Binding,Protein, Microfilament,Proteins, Actin-Binding,Proteins, Microfilament
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D010750 Phosphoproteins Phosphoprotein
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004004 Dichlororibofuranosylbenzimidazole An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation. Dichlorobenzimidazole Riboside,5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol,5,6-Dichloro-1-beta-ribofuranosylbenzimidazole,DRB,5,6 Dichloro 1 beta D ribofuranosyl 1 H benzimidazol,5,6 Dichloro 1 beta ribofuranosylbenzimidazole,Riboside, Dichlorobenzimidazole
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein

Related Publications

A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
November 2000, Circulation research,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
November 2013, Biomaterials,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
February 2002, Molecular pharmacology,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
February 2015, Life sciences,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
February 2012, Transfusion,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
January 2019, Clinical and experimental hypertension (New York, N.Y. : 1993),
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
January 2018, Basic research in cardiology,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
May 1994, The Journal of biological chemistry,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
October 2002, The Journal of biological chemistry,
A Smolenski, and C Bachmann, and K Reinhard, and P Hönig-Liedl, and T Jarchau, and H Hoschuetzky, and U Walter
January 2010, Molecular medicine reports,
Copied contents to your clipboard!